Northern Trust’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-103,493
Closed -$72.5K 4538
2023
Q4
$72.5K Buy
+103,493
New +$72.5K ﹤0.01% 4167
2023
Q2
Sell
-3,495
Closed -$28.4K 4607
2023
Q1
$28.4K Hold
3,495
﹤0.01% 4382
2022
Q4
$41.4K Hold
3,495
﹤0.01% 4326
2022
Q3
$49K Hold
3,495
﹤0.01% 4329
2022
Q2
$123K Sell
3,495
-203
-5% -$7.14K ﹤0.01% 4091
2022
Q1
$148K Hold
3,698
﹤0.01% 4230
2021
Q4
$157K Hold
3,698
﹤0.01% 4285
2021
Q3
$251K Hold
3,698
﹤0.01% 4074
2021
Q2
$285K Hold
3,698
﹤0.01% 3969
2021
Q1
$243K Buy
3,698
+1,241
+51% +$81.5K ﹤0.01% 4041
2020
Q4
$83K Buy
2,457
+133
+6% +$4.49K ﹤0.01% 4150
2020
Q3
$127K Sell
2,324
-136
-6% -$7.43K ﹤0.01% 3910
2020
Q2
$92K Buy
2,460
+876
+55% +$32.8K ﹤0.01% 3941
2020
Q1
$40K Hold
1,584
﹤0.01% 3988
2019
Q4
$78K Hold
1,584
﹤0.01% 3978
2019
Q3
$78K Buy
1,584
+321
+25% +$15.8K ﹤0.01% 3969
2019
Q2
$115K Hold
1,263
﹤0.01% 3944
2019
Q1
$187K Sell
1,263
-1,111
-47% -$164K ﹤0.01% 3795
2018
Q4
$373K Sell
2,374
-49
-2% -$7.7K ﹤0.01% 3622
2018
Q3
$594K Buy
2,423
+480
+25% +$118K ﹤0.01% 3602
2018
Q2
$435K Sell
1,943
-50
-3% -$11.2K ﹤0.01% 3637
2018
Q1
$489K Buy
1,993
+670
+51% +$164K ﹤0.01% 3573
2017
Q4
$408K Buy
1,323
+529
+67% +$163K ﹤0.01% 3606
2017
Q3
$291K Buy
794
+64
+9% +$23.5K ﹤0.01% 3686
2017
Q2
$266K Buy
730
+38
+5% +$13.8K ﹤0.01% 3707
2017
Q1
$206K Buy
692
+205
+42% +$61K ﹤0.01% 3788
2016
Q4
$107K Buy
487
+60
+14% +$13.2K ﹤0.01% 3886
2016
Q3
$102K Buy
427
+7
+2% +$1.67K ﹤0.01% 3890
2016
Q2
$82K Sell
420
-161
-28% -$31.4K ﹤0.01% 3934
2016
Q1
$249K Sell
581
-211
-27% -$90.4K ﹤0.01% 3656
2015
Q4
$299K Buy
792
+59
+8% +$22.3K ﹤0.01% 3637
2015
Q3
$199K Buy
733
+508
+226% +$138K ﹤0.01% 3749
2015
Q2
$66K Sell
225
-47
-17% -$13.8K ﹤0.01% 4020
2015
Q1
$75K Sell
272
-26
-9% -$7.17K ﹤0.01% 4097
2014
Q4
$129K Hold
298
﹤0.01% 3931
2014
Q3
$98K Sell
298
-35
-11% -$11.5K ﹤0.01% 4023
2014
Q2
$112K Buy
+333
New +$112K ﹤0.01% 3985